XMRV Retrovirus Whittemore Peterson Institute Science Mikovits Peterson Chronic Fatigue Syndrome
XMRV Retrovirus: Round up 22: WPI Press Release, ESME, 74 CFSAC meeting videos
WordPress Shortlink: http://wp.me/p5foE-2jN
Press Releases
PDF here: WPI Release Diagnostic Test
http://www.wpinstitute.org/WPI%20Release%20Diagnostic%20Test.pdf
FOR IMMEDIATE RELEASE
Frankie Vigil
R&R Partners
775-336-4555
frankie.vigil@rrpartners.com
Viral Immune Pathology Diagnostics Introduces New Test for XMRV Patients and Clinicians
-Net proceeds from test dedicated to further WPI research-
RENO, Nev. – The Whittemore Peterson Institute (WPI) has recently published a research study revealing the prevalence of XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, ME/CFS or what has most recently been called, X associated neuro-immune disease, (XAND). In response to an overwhelming request for a diagnostic test for XMRV, WPI has temporarily agreed to allow Viral Immune Pathology Diagnostics (VIP Dx) to begin offering the identical tests that have been extensively validated using the same technology developed by Drs. Lombardi and Mikovits and their colleagues as reported in Science.
VIP Dx is a small state certified laboratory in Reno, Nevada that was formed in response to the September 11, 2001 crisis which resulted in the cessation of blood sample shipments between the United States and Europe. Faced with the loss of important lab tests impacting patients with neuro-immune diseases, the Whittemore family made the decision to support the lab in Reno.
“Our family made it possible for the lab to not only continue delivering diagnostic tests to doctors, but also help the WPI bring cutting edge biomarkers of disease to this field of medicine, such as the tests for XMRV,” said Annette Whittemore, Founder and President of WPI. “Tests conducted for XMRV, and other tests that support the diagnostic process in this field, will support the continuation of vital work at WPI through our donation of all of our net proceeds.”
XMRV test acceptance commenced at VIP Dx this month.
For more information about the XMRV test kit, visit www.vipdx.com
Whittemore Peterson Institute http://www.wpinstitute.org/
The Whittemore Peterson Institute for Neuro-Immune Disease exists to bring discovery, knowledge, and effective treatments to patients with illnesses caused by acquired dysregulation of the immune system and the nervous system, often resulting in lifelong disease and disability. The WPI is the first institute in the world dedicated to neuro immune diseases, integrating patient treatment, basic and clinical research and medical education.
—————-
CFSAC Two Day meeting: NIH videocasts now available plus 74 Video segments
http://cfsknowledgecenter.ning.com/video
74 videos covering the CFSAC Two Day meeting (29 – 30 October) on Dan Moricoli’s Ning ME-CFS Community.
—————-
NIH will be counting viewing figures to assess interest in making videocasts for these meetings available worldwide – so please view the videocasts on the NIH site:
Videocasts of CFSAC meeting 29-30 October 2008
Around 12 hours of video of the two day CFSAC meeting is now available at:
http://videocast.nih.gov/PastEvents.asp
Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 1
Thursday, October 29, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 06:43:49
http://videocast.nih.gov/PastEvents.asp
Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2
Friday, October 30, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 05:15:09
Presentation
Dr David Bell’s PowerPoint slides: http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt
———-
Media
The Street | 3 November 2009
http://www.thestreet.com/_yahoo/story/10620979/1/hemispherx-cops-to-ampligen-fda-delay.html
Ref: Hemispherx press release:
http://finance.yahoo.com/news/Hemispherx-Biopharma-Updates-pz-1535703186.html
See also:
http://philadelphia.bizjournals.com/philadelphia/stories/2009/11/02/daily2.html
Hemispherx cops to Ampligen FDA delay
PHILADELPHIA, Pa. (TheStreet) – Hemispherx Biopharma(HEB Quote) issued an “update” to the regulatory status of its chronic fatigue syndrome drug Ampligen in which the company essentially admits that its prior public statements were false and misleading.
Monday’s statement was likely crafted by Hemispherx’s lawyers as a way to help CEO Bill Carter wiggle out of public statements he made in May and June claiming the Ampligen application to the U.S. Food and Drug Administration to be complete. Carter insisted regulators weren’t asking for any additional information on Ampligen.
—————-
Patient organisation statements
ESME www.esme-eu.com
Dear Whittemore Peterson Institute,
The Scientific Panel, the Board of Directors and the staff of ESME wish to congratulate the Whittemore Peterson Institute on the groundbreaking work they are performing in the area of neuro-immune diseases and especially their work with the XMRV virus. We applaud the thoroughness of your research and the openness with which you are sharing this research information with the world. We believe that by sharing scientific knowledge with this openness, you are starting a new era of scientific cooperation.
ESME would like to help the Whittemore Peterson Institute with information flow in Europe. We have the capacity to professionally translate information to Danish, Dutch, German, Norwegian, French and Spanish and we have a professional website where information can be posted in any of these languages: www.esme-eu.com
ESME has also established a database of approximately 3000 e-mail addresses of European scientists, doctors, medical associations, national and regional ME associations, politicians, journalists and other people interested in ME/CFS. This database allows us to easily distribute information to professionals in many fields. We will gladly use our resources to assist the Whittemore Peterson Institute with the distribution of information in Europe.
In 2009, ESME held two conferences in Norway to educate healthcare personal (and patients) about the diagnostics, treatment, causes and consequences of ME/CFS. ESME will continue organizing these conferences in the coming years throughout Europe. We would like to invite a representative of the WPI to be a guest speaker at future European conferences to help us inform and train European MD’s and therapists better.
With Kind Regards,
ESME
—————-
Commentary
Cort Johnson’s Phoenix Rising website: http://aboutmecfs.org/Rsrcs/XMRVResources.aspx
Cort Johnson’s Blog and comments: http://aboutmecfs.org/blog/
Cort Johnson’s Forums: http://forums.aboutmecfs.org/
—————-
About.com Fibromyalgia and CFS Blog | 5 November 2009
XMRV & Updated Mechanism Theory of Chronic Fatigue Syndrome
The XMRV Discovery Series
Dr. Daniel Peterson, one of the researchers involved in the possibly groundbreaking XMRV findings, testified before the NIH’s Chronic Fatigue Syndrome Advisory Committee Oct. 29. Among the many things he presented was an updated theory of how chronic fatigue syndrome (CFS or ME/CFS) develops. (Thanks to Dr. David S. Bell and his newsletter, Lyndonville News for putting this into language that was easier to understand!)
—————-
For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, go here: http://wp.me/p5foE-272
For Science paper go here: http://wp.me/p5foE-2is
Click here for all previous XMRV Round ups and postings in reverse date order: https://meagenda.wordpress.com/category/xmrv/
The Definition Petition
Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_researchIf you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com
meagenda.wordpress.com 